$NRIX insider trading

Over the last 12 months, Nurix Therapeutics insiders reported no purchases and 11 sales totaling $2.0M across SEC Form 4 filings. 73% of the activity was filed under pre-arranged 10b5-1 trading plans.

$2.0M
11
3
73%
Side
$10K$100K$1.0MJun '26JulAug
Ring Christine
Hansen Gwenn
van Houte Hans

All insider trades

Aug 5, 2026Hansen Gwenn▼ Sale4,356$25$109K-3.6%
Aug 4, 2026Hansen Gwenn▼ Sale4,111$24.36$100K-3.4%
Aug 4, 2026van Houte Hans▼ Sale4,761$24.36$116K-10.6%
Aug 3, 2026Ring Christine▼ Sale16,589$23.05$382K-64.6%
Jul 30, 2026van Houte Hans▼ Sale2,845$23.38$67K-6%
Jul 30, 2026Ring Christine▼ Sale3,847$23.38$90K-16.2%
Jul 30, 2026Hansen Gwenn▼ Sale3,847$23.38$90K-3.1%
Jul 2, 2026Ring Christine▼ Sale11,008$23.56$259K-44.8%
Jun 25, 2026Hansen Gwenn▼ Sale5,394$20$108K-4.5%
Jun 25, 2026Ring Christine▼ Sale28,935$20.06$581K-68.1%
Jun 2, 2026Ring Christine▼ Sale8,148$16.6$135K-37.5%

Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $NRIX feed.

NRIX Insider Trading — Form 4 Buys & Sells | alphai